I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Sproule, Stephanie
22
results:
Search for persons
X
Format
Online (22)
Mediatypes
Articles (Online) (11)
OpenAccess-fulltext (11)
Sorted by: Relevance
Sorted by: Year
?
1
Ongoing Analytical Procedure Performance Verification Using..:
Borman, Phil J.
;
Guiraldelli, Amanda M.
;
Weitzel, Jane
...
Analytical Chemistry. 96 (2024) 3 - p. 966-979 , 2024
Link:
https://doi.org/10.1021/..
?
2
Immune correlates analysis of a phase 3 trial of the AZD122..:
Benkeser, David
;
Fong, Youyi
;
Janes, Holly E.
...
npj Vaccines. 8 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
3
AZD1222-induced nasal antibody responses are shaped by prio..:
Aksyuk, Anastasia A.
;
Bansal, Himanshu
;
Wilkins, Deidre
...
Cell Reports Medicine. 4 (2023) 1 - p. 100882 , 2023
Link:
https://doi.org/10.1016/..
?
4
Robust humoral and cellular recall responses to AZD1222 att..:
Maaske, Jill
;
Sproule, Stephanie
;
Falsey, Ann R.
...
Frontiers in Immunology. 13 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
5
Durability of protection and immunogenicity of AZD1222 (ChA..:
Sobieszczyk, Magdalena E.
;
Maaske, Jill
;
Falsey, Ann R.
...
Journal of Clinical Investigation. 132 (2022) 18 - p. , 2022
Link:
https://doi.org/10.1172/..
?
6
1953. Immune responses, viral shedding, and COVID-19 sympto..:
Sobieszczyk, Magdalena E
;
Falsey, Ann R
;
Luetkemeyer, Anne F
...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022
Link:
https://doi.org/10.1093/..
?
7
LB6. Asymptomatic Infection and Duration of Viral Shedding ..:
Sobieszczyk, Magdalena
;
Falsey, Ann R
;
Robb, Merlin L
...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S804-S804 , 2021
Link:
https://doi.org/10.1093/..
?
8
Role of Antibodies in Protection Against Ebola Virus in Non..:
Warfield, Kelly L
;
Howell, Katie A
;
Vu, Hong
...
The Journal of Infectious Diseases. 218 (2018) suppl_5 - p. S553-S564 , 2018
Link:
https://doi.org/10.1093/..
?
9
Efficacy and safety of benralizumab for patients with sever..:
Bleecker, Eugene R
;
FitzGerald, J Mark
;
Chanez, Pascal
...
The Lancet. 388 (2016) 10056 - p. 2115-2127 , 2016
Link:
https://doi.org/10.1016/..
?
10
Durability of protection and immunogenicity of AZD1222 (ChA..:
Sobieszczyk, Magdalena E
;
Maaske, Jill
;
Falsey, Ann R
...
The Journal of clinical investigation. , 2022
Link:
http://hdl.handle.net/10..
?
11
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Co..:
Falsey, Ann R
;
Sobieszczyk, Magdalena E
;
Hirsch, Ian
...
qt3gt0378n. , 2021
Link:
https://escholarship.org..
?
12
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Co..:
Falsey, Ann R
;
Sobieszczyk, Magdalena E
;
Hirsch, Ian
...
New England Journal of Medicine. , 2021
Link:
http://hdl.handle.net/10..
?
13
Oral Glucocorticoid-Sparing Effect of Benralizumab in Sever..:
Nair, Parameswaran
;
Wenzel, Sally
;
Rabe, Klaus F
...
info:eu-repo/semantics/altIdentifier/doi/10.1056/NEJMoa1703501. , 2017
Link:
https://hal.science/hal-..
?
14
Oral Glucocorticoid-Sparing Effect of Benralizumab in Sever..:
Nair, Parameswaran
;
Wenzel, Sally
;
Rabe, Klaus F
...
info:eu-repo/semantics/altIdentifier/doi/10.1056/NEJMoa1703501. , 2017
Link:
https://hal.archives-ouv..
?
15
Immune correlates analysis of a phase 3 trial of the AZD122..:
David Benkeser
;
Youyi Fong
;
Holly E. Janes
...
https://doi.org/10.1038/s41541-023-00630-0. , 2023
Link:
https://doi.org/10.1038/..
1-15